This market resolves YES if Amberlynn Reid publicly announces (via YouTube, TikTok, Instagram, Twitter/X, or other social media platforms) that she is no longer taking Wegovy or any GLP-1 medication (including semaglutide, Ozempic, or similar weight-loss drugs) before April 1st, 2026. The announcement must be made directly by Amberlynn Reid herself, not by third parties or commentary channels.

This market resolves NO if no such announcement is made by April 1st, 2026, or if she only announces a temporary pause rather than permanently stopping the medication.

Background

Amberlynn Reid is an American YouTuber and social media personality known for her mukbang videos. The FDA approved the Wegovy pill on December 22, with the same active ingredient as Ozempic and Wegovy, which is semaglutide. The Wegovy pill launched in January 2026.

Considerations

Amberlynn Reid has a documented history of starting and stopping various weight-loss interventions. Given her public platform and the significant attention her weight-loss journey receives from online communities, any announcement about discontinuing medication would likely be made publicly. However, she may choose to stop taking the medication without making an explicit announcement, which would resolve this market as NO.

This description was generated by AI.